FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to therapy and urology, and concerns the enhancement of the pharmacological activity of the activated-potentiated form of antibodies to prostate-specific antigen. For the purpose, an effective amount of a pharmaceutical composition comprising an activated-potentiated form of antibodies to a prostate-specific antigen and an activated potentiated form of antibodies to endothelial ΝΟ-synthase are administered.
EFFECT: activated-potentiated antibodies to endothelial ΝΟ-synthase increase the therapeutic efficacy of antibodies to prostate-specific antigen, which provides effective treatment of prostate diseases.
8 cl, 4 tbl, 2 ex
